Announcements Trials
Browse Landscape

Phase

Phase 1 18Phase NA 2Phase 2 2Phase 1/2 2

Status

Not yet recruiting 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 699Breast Neoplasms 629Neoplasms 582Leukemia, Myeloid, Acute 481Colorectal Neoplasms 455Multiple Myeloma 444Melanoma 424Prostatic Neoplasms 383Neoplasm Metastasis 370Pancreatic Neoplasms 361Recurrence 347Lymphoma 340Ovarian Neoplasms 322Lung Neoplasms 297Lymphoma, Non-Hodgkin 295Leukemia 287Glioblastoma 275Precursor Cell Lymphoblastic Leukemia-Lymphoma 249Stomach Neoplasms 246Leukemia, Lymphocytic, Chronic, B-Cell 235Carcinoma, Hepatocellular 231Squamous Cell Carcinoma of Head and Neck 219Lymphoma, Large B-Cell, Diffuse 217Myelodysplastic Syndromes 212Carcinoma, Renal Cell 210Lymphoma, Follicular 183Head and Neck Neoplasms 172Brain Neoplasms 169Triple Negative Breast Neoplasms 167Lymphoma, Mantle-Cell 167

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × Solid Cancers × Clear all
NCT07510841 2026-04-06

JY016 Injection in Patients With Advanced Solid Tumors Expressing EGFR

Biotech Pharmaceutical Co., Ltd.

Phase 1/2 Not yet recruiting
228 enrolled

Solid Cancers

NCT07030478 2025-06-22

A Study to Evaluate the Safety and Tolerability of EP0089

Ellipses Pharma

Phase 1/2 Not yet recruiting
190 enrolled
Other solid neoplasm

Solid Cancers

Data powered by HemOnc (CC BY 4.0) Colophon âš¡